Iskenderun Demir ve Celik AS
IST:ISDMR.E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iskenderun Demir ve Celik AS
IST:ISDMR.E
|
TR |
|
Tanvex BioPharma Inc
TWSE:6541
|
KY |
Cash Flow Statement
Cash Flow Statement
Iskenderun Demir ve Celik AS
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
2 423
|
3 269
|
4 866
|
7 475
|
6 468
|
8 073
|
9 674
|
7 317
|
6 726
|
3 220
|
(2 061)
|
(1 824)
|
4 602
|
9 771
|
14 180
|
14 323
|
14 254
|
10 957
|
10 182
|
10 744
|
6 112
|
|
| Depreciation & Amortization |
776
|
802
|
869
|
903
|
928
|
1 118
|
1 313
|
1 551
|
1 607
|
1 664
|
1 745
|
2 014
|
3 001
|
3 439
|
3 898
|
4 161
|
4 000
|
4 181
|
4 413
|
4 883
|
5 201
|
|
| Other Non-Cash Items |
1 036
|
1 260
|
2 199
|
2 642
|
2 957
|
3 244
|
3 479
|
2 935
|
1 405
|
91
|
1 453
|
2 185
|
1 636
|
168
|
(2 958)
|
(4 037)
|
(7 331)
|
(5 578)
|
(5 054)
|
(4 971)
|
807
|
|
| Cash Taxes Paid |
1 038
|
1 243
|
1 468
|
2 337
|
3 104
|
4 615
|
5 650
|
6 140
|
5 704
|
3 836
|
2 339
|
725
|
83
|
101
|
119
|
119
|
36
|
18
|
0
|
205
|
205
|
|
| Cash Interest Paid |
41
|
36
|
18
|
19
|
34
|
49
|
147
|
257
|
392
|
830
|
1 149
|
1 370
|
1 877
|
2 072
|
2 185
|
3 078
|
2 708
|
3 249
|
3 423
|
2 856
|
3 006
|
|
| Change in Working Capital |
(201)
|
(1 140)
|
(2 574)
|
(6 247)
|
(9 316)
|
(11 162)
|
(14 144)
|
(15 664)
|
(7 432)
|
(3 390)
|
10
|
7 208
|
4 582
|
358
|
(601)
|
(3 357)
|
5 637
|
14 978
|
25 656
|
32 578
|
24 879
|
|
| Cash from Operating Activities |
4 036
N/A
|
4 191
+4%
|
5 359
+28%
|
4 773
-11%
|
1 037
-78%
|
1 274
+23%
|
322
-75%
|
(3 861)
N/A
|
2 307
N/A
|
1 585
-31%
|
1 146
-28%
|
9 583
+736%
|
13 821
+44%
|
13 737
-1%
|
14 519
+6%
|
11 089
-24%
|
16 560
+49%
|
24 538
+48%
|
35 196
+43%
|
43 233
+23%
|
36 999
-14%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(1 075)
|
(1 357)
|
(1 588)
|
(1 971)
|
(2 266)
|
(2 505)
|
(2 907)
|
(3 371)
|
(3 472)
|
(3 776)
|
(5 652)
|
(6 307)
|
(9 722)
|
(12 037)
|
(14 103)
|
(16 138)
|
(14 956)
|
(14 408)
|
(10 373)
|
(7 792)
|
(5 371)
|
|
| Other Items |
(239)
|
(101)
|
(203)
|
(303)
|
(183)
|
(548)
|
(334)
|
15
|
(126)
|
(366)
|
(1 666)
|
(3 092)
|
(2 703)
|
(1 781)
|
(1 430)
|
31
|
(2 062)
|
(2 889)
|
(3 198)
|
(3 686)
|
(1 820)
|
|
| Cash from Investing Activities |
(1 314)
N/A
|
(1 457)
-11%
|
(1 791)
-23%
|
(2 274)
-27%
|
(2 450)
-8%
|
(3 053)
-25%
|
(3 241)
-6%
|
(3 356)
-4%
|
(3 598)
-7%
|
(4 142)
-15%
|
(7 318)
-77%
|
(9 400)
-28%
|
(12 426)
-32%
|
(13 818)
-11%
|
(15 533)
-12%
|
(16 107)
-4%
|
(17 018)
-6%
|
(17 297)
-2%
|
(13 571)
+22%
|
(11 478)
+15%
|
(7 192)
+37%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Debt |
(3 082)
|
759
|
1 762
|
3 105
|
8 804
|
9 790
|
7 749
|
11 084
|
4 312
|
480
|
2 785
|
2 326
|
1 474
|
2 569
|
11 511
|
5 295
|
6 974
|
7 249
|
(4 930)
|
(1 047)
|
(813)
|
|
| Cash Paid for Dividends |
(522)
|
(4 232)
|
(4 233)
|
(3 711)
|
(8 059)
|
(13 006)
|
(13 045)
|
(13 045)
|
(8 697)
|
(40)
|
0
|
0
|
0
|
0
|
(1 450)
|
(1 450)
|
(1 450)
|
0
|
(0)
|
(725)
|
(725)
|
|
| Other |
202
|
295
|
444
|
652
|
753
|
1 002
|
859
|
594
|
238
|
(381)
|
(696)
|
(923)
|
(773)
|
(640)
|
(257)
|
(690)
|
(379)
|
(577)
|
(661)
|
(217)
|
(280)
|
|
| Cash from Financing Activities |
(3 402)
N/A
|
(3 178)
+7%
|
(2 027)
+36%
|
46
N/A
|
1 498
+3 133%
|
(2 214)
N/A
|
(4 437)
-100%
|
(1 367)
+69%
|
(4 147)
-203%
|
58
N/A
|
2 089
+3 474%
|
1 404
-33%
|
701
-50%
|
1 930
+175%
|
9 805
+408%
|
3 155
-68%
|
5 146
+63%
|
5 223
+1%
|
(5 591)
N/A
|
(1 989)
+64%
|
(1 818)
+9%
|
|
| Change in Cash | ||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
661
|
1 062
|
1 242
|
1 158
|
8 656
|
9 074
|
9 665
|
9 395
|
3 144
|
2 157
|
1 950
|
3 655
|
2 978
|
2 503
|
3 868
|
2 310
|
2 516
|
4 164
|
2 923
|
3 597
|
3 916
|
|
| Net Change in Cash |
(20)
N/A
|
618
N/A
|
2 784
+350%
|
3 703
+33%
|
8 741
+136%
|
5 082
-42%
|
2 310
-55%
|
810
-65%
|
(2 294)
N/A
|
(341)
+85%
|
(2 133)
-525%
|
5 241
N/A
|
5 074
-3%
|
4 351
-14%
|
12 659
+191%
|
448
-96%
|
7 204
+1 508%
|
16 628
+131%
|
18 957
+14%
|
33 363
+76%
|
31 904
-4%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
2 961
N/A
|
2 834
-4%
|
3 771
+33%
|
2 802
-26%
|
(1 229)
N/A
|
(1 231)
0%
|
(2 585)
-110%
|
(7 232)
-180%
|
(1 165)
+84%
|
(2 191)
-88%
|
(4 506)
-106%
|
3 275
N/A
|
4 098
+25%
|
1 699
-59%
|
416
-75%
|
(5 049)
N/A
|
1 604
N/A
|
10 130
+531%
|
24 823
+145%
|
35 441
+43%
|
31 627
-11%
|
|